Skip to content
OpenCapital
Get started

Merck & Co. MRK Enterprise value

Enterprise value at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$158.92B-2.6%
Pfizer logo
PfizerPFE
$222.4B+9.2%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$622.06B+50.5%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$81.42B+18.1%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$18.99B+198%
Amgen logo
AmgenAMGN
$246.43B+9.9%

Other financials

Income statement

See full
Revenue$16.3B+4.9%
Gross profit$12.1B-0.2%
Net income-$4.2B-183%
EPS (diluted)-$1.72-186%

Balance sheet

See full
Cash & equivalents$5.4B-38.2%
Total debt$49.1B+35.8%
Total equity$45.9B-5.1%
Total assets$128.69B+11.8%

Cash flow

See full
Operating cash flow$3.9B+56.7%
CapEx$991.0M-25.4%
Free cash flow$2.9B+150%

Valuation

See full
Market cap$285.12B+31.2%
P/E31.9×+19.4×
P/S4.3×+0.9×

Profitability

See full
Gross margin73.9%-2.5pp
Net margin13.6%-13.7pp

Returns & leverage

See full
Return on equity19%-20.3pp
Debt / equity1.1×+0.3×
Current ratio1.3×-0.1×

Where this comes from

Calculated from Merck & Co.’s reported figures.

$297.40Bmarket cap+$49.1Btotal debt−$5.4Bcash and equivalents=$341.11B

The official record: Merck & Co.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merck & Co.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merck & Co.'s enterprise value?
Merck & Co. (MRK) reported enterprise value of $341.11B in Q1 2026.
How has Merck & Co.'s enterprise value changed year-over-year?
Merck & Co.'s enterprise value increased by 34.2% year-over-year, from $254.17B to $341.11B.
What is the long-term trend for Merck & Co.'s enterprise value?
Over 4 years (2021 to 2025), Merck & Co.'s enterprise value has grown at a 3.9% compound annual growth rate (CAGR), from $875.16B to $1.02T.
What does enterprise value mean?
What it would cost to buy the entire business, debt included and cash netted out.
How do you interpret enterprise value?
The capital-structure-neutral valuation base — used in EV/EBITDA and EV/Sales to compare companies with different leverage on a like-for-like footing.
How does enterprise value compare across companies?
Comparable across non-financial companies via the EV multiples it feeds; not used for banks and insurers.